Related Experiment Video

Updated: Jul 13, 2026

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents
08:03

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents

Published on: June 6, 2018

Y-27632 improves the erectile dysfunction with ageing in SD rats through adjusting the imbalance between nNo and the

B H Gao1, S T Zhao, F W Meng

  • 1Department of Urology, Second Hospital and Qilu Hospital, Shandong University School of Medicine, Jinan, China.

Andrologia
|August 9, 2007
PubMed

Insights

Y-27632 improves erectile function in aging rats by correcting an imbalance between neuronal nitric oxide synthase (nNOS) and Rho-kinase pathways. This suggests a therapeutic target for age-related erectile dysfunction.

Area of Science:

  • Urology
  • Physiology
  • Pharmacology

Background:

  • Aging is associated with impaired erectile function.
  • Nitric oxide synthase (NOS) and Rho-kinase pathways play critical roles in regulating erectile function.
  • An imbalance between these pathways may contribute to age-related erectile dysfunction.

Purpose of the Study:

  • To investigate the association between the imbalance of nNOS and Rho-kinase pathways and erectile function in young and old SD rats.
  • To evaluate the therapeutic effect of Y-27632, a Rho-kinase inhibitor, on erectile function in aging rats.

Main Methods:

  • Western blot analysis was used to quantify nNOS and Rho-kinase protein expression in young and old SD rats.
  • The imbalance value was calculated by subtracting nNOS from Rho-kinase levels.
  • Erectile function was assessed by measuring intracavernosal pressure (ICP) to mean arterial pressure (MAP) ratio before and after intracavernosal administration of Y-27632.

Main Results:

  • Old rats exhibited decreased nNOS and increased Rho-kinase protein levels compared to young rats, indicating an imbalance.
  • The imbalance value between nNOS and Rho-kinase was significantly higher in old rats.
  • Y-27632 administration significantly improved erectile function in old rats, correlating with the degree of nNOS and Rho-kinase imbalance.

Conclusions:

  • Impaired erectile function in aging SD rats is linked to an imbalance between nNOS and Rho-kinase activity.
  • Y-27632 effectively improves erectile function in old rats by modulating this imbalance.
  • Targeting the nNOS and Rho-kinase pathways presents a potential therapeutic strategy for age-related erectile dysfunction.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...